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1. Introduction 
The human retina is a complex, layered tissue responsible for the perception of the visual 
stimuli coming from the external environment. Since the visual inputs account for about 
30% of our sensory stimulations, it is not surprising that partial or complete blindness 
results in a strong decrease of life quality. Several diseases affect the retina, often leading to 
degeneration of one or several cell types. The damage induced by these diseases is often 
irreversible, thus leading to a permanent loss of the visual ability. 
Over the last decades significant progress has been made to elucidate the molecular basis of 
retinal degenerative diseases. This knowledge is necessary in order to design valid 
approaches for the treatment of retinopathies. However, the extreme genetic heterogeneity 
of these diseases, combined with the complex molecular nature of the underlying 
degenerative processes, has hampered the design of definitive therapies. Indeed, 
pharmacological treatments are only partially effective and tend to treat the effect of the 
disease, not the underlying cause. Furthermore, despite the recent technical advances, drug 
delivery into the retina may reveal challenging (reviewed in Yasukawa et al., 2011). On the 
other hand, gene therapy reveals as a promising alternative approach for inherited 
retinopathies. However, although significant progress has been achieved in treating 
recessive forms of retinopathies, dominant or multi-factorial forms are more difficult to 
treat, revealing the current limits of gene-based therapies (Farrar et al., 2010). 
Thus, other strategies are needed to treat these diseases. One interesting approach, which 
will not be covered in this review, is the stem cell-based therapy, where stem cells can be 
differentiated in vitro and then transplanted to replace dead cells (for a review see Bull and 
Martin, 2011; Dahlmann-Noor et al., 2010; Locker et al., 2010). Another promising strategy is 
to promote the regeneration in vivo of the tissues (or organs) affected by the disease. 
Although the field of regenerative medicine is relatively young, the continuous findings on 
the mechanisms regulating regeneration in model organisms is improving our knowledge 
on the regenerative phenomena, and in some cases this information can be used to induce or 
increase regeneration in particular contexts (reviewed in Stoick-Cooper et al., 2007). 
In the first part of this review, we will introduce some of the most common retina 
degenerative diseases that affect people worldwide, namely retinitis pigmentosa (RP) and 
age-related macular degeneration (AMD), providing the reader with a general description 
of these retinopathies. In the second part, we will discuss some of the animal models used 
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to mimic particular features of retinal diseases, useful to understand the molecular 
mechanisms underlying retina degeneration. The information gathered from these models 
will be instrumental for the design of accurate and effective therapies. In the final part of 
this chapter we will present animal models, like transgenic frogs or fishes, capable of 
regenerating their damaged retinas. The use of these models is generating important and 
promising knowledge on the molecular pathways regulating neural repair, which could 
one day be used to stimulate retinal regeneration in humans. Thus, we will also review 
the cellular sources and molecular components playing a fundamental role in in vivo 
regeneration. Recent studies, aimed at stimulating regeneration processes in vivo by 
genetic or pharmacological manipulation of signaling pathways, will also be covered in 
this part. 
2. Retinal diseases 
Retinopathy is a generic term regarding non-inflammatory diseases affecting the retina. The 
damage usually affects severely the vision ability, especially when the macula (the region of 
human retina where cone photoreceptors concentrate) or the optic nerve are concerned. 
Retinopathies can arise as a consequence of other disorders, for example diabetes, or as a 
consequence of aging. The degeneration process is generally progressive, resulting in severe 
sight impairment in older patients. Furthermore, although the pathology affects primarily a 
given cell type, secondary events can arise extending the degeneration to other cell types. In 
some cases, genetic mutations are the underlying causes of the pathology, which can 
manifest alone or as a part of a syndromic disease. Due to their prevalence and to the highly 
debilitating loss of sight they cause, RP and AMD gained much attention in medical and 
clinical research.   
2.1 Retinitis pigmentosa  
RP is a group of inherited genetic diseases with a worldwide prevalence of 1 on 4000 
individuals in the industrialized world. RP was first described around 1855 by the Dutch 
ophthalmologist Franciscus C. Donders, while observing pigmented speckles in a patient’s 
degenerating retina. In the most typical form of RP, rod photoreceptors undergo a gradual 
degeneration, eventually leading to their death which occurs either by apoptotic or non-
apoptotic mechanisms (reviewed in Berson, 1993; Chang et al., 1993; Hartong et al., 2006; 
Sancho-Pelluz et al., 2008). As a result, the loss of rods compromises the peripheral and 
night vision, as evidenced by the restriction of visual field (tunnel vision) and night 
blindness in RP patients. 
As the disease progresses, the cones residing in the macula are also affected, degenerating 
after the rod photoreceptor death. As a consequence, other symptoms are manifested like 
color-blindness and loss of the central vision, resulting in total visual impairment (Berson, 
1993; Hartong et al., 2006). The onset of RP symptoms is variable: some patients develop 
visual impairments during childhood, while others remain asymptomatic until mid-
adulthood. There is no treatment to cure patients with RP, who usually become legally blind 
by the 40th year of age, because of a severe constriction of the visual field. Retinas of patients 
affected by RP undergo dramatic changes, as can be observed by fundus examination. 
Besides accumulation of pigmented deposits, retina atrophy, attenuation of retinal vessels 
and reactive gliosis are also associated with RP (reviewed in Hamel, 2006). 
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The pattern of inheritance of RP is complex and depends on the gene being affected. 
Generally, RP presents as a monogenic disease that can be inherited as autosomal dominant 
(24% of the cases), recessive (41%), or X-linked (22%). However, the remaining of the cases 
are considered to result from non-Mendelian inheritance or environmental factors (reviewed 
in Wright et al., 2010). So far, more than 45 genes have been shown to be involved in RP 
(http://www.sph.uth.tmc.edu/retnet/), which highlights the high genetic heterogeneity of 
the disease. Nonetheless, the significance of gene mutations in RP, as well as the molecular 
mechanisms leading to photoreceptors degeneration, is still poorly understood. 
2.2 Age-related macular degeneration  
AMD is a group of conditions that affect the central retina, particularly the macula. AMD 
represents the leading cause of vision loss in individuals above the 60th year of age, with a 
prevalence of 30% among people older than 75. Among these patients, about 10% show 
signs of advanced AMD, which is characterized by an extensive deterioration of central 
vision, with a tremendous impact on normal daily activities such as reading or 
deambulating (reviewed in Prasad et al., 2010). Age is one of the risk factors for this disease. 
It is estimated that, since the life expectancy is increasing, with an escalation of people 
reaching the age of 70 or greater, the prevalence of AMD in 2020 will double (for reviews, 
see Liutkeviciene et al., 2010; Prasad et al., 2010). Besides age, other factors such as oxidative 
stress and genetics are known to play a major role in the onset of the disease. However, it is 
important to note that the precise causes of AMD remain still unclear. Although AMD 
affects mainly elderly people, young may also be affected in the context of genetic 
(monogenic) disorders characterized by early onset, affecting people younger than 40 
(reviewed in Rattner and Nathans, 2006). 
Initially, AMD is characterized by the presence of large and poorly demarcated “drusen”, 
aggregates of lipids and proteins which accumulate between the retinal pigmented 
epithelium (RPE) and the Bruch’s membrane. RPE underlying these drusen displays some 
abnormalities such as hypo-pigmentation. Although at this stage there is no significant 
impairment on visual acuity, there is a high risk of progression to more severe forms of 
AMD, or late AMD. Late AMD is characterized by localized degeneration of RPE 
(geographic atrophy or dry - non exudative – AMD). Eventually, new blood vessels from the 
choroid above the RPE can grow into the macula, leading to the so-called exudative (or wet) 
AMD. These blood vessels are very fragile and may result in local bleeding, leading to 
blurry vision and visual distortion. Ultimately, these lesions can form a fibrous scar, which 
typically result in irreversible loss of central vision (Prasad et al., 2010; Rattner and Nathans, 
2006). It is important to note that, although RPE cells are primarily affected by AMD, it is the 
subsequent loss of photoreceptors that accounts for vision loss. 
As stated above, genetics play also a role in macular degeneration. In particular, some 
inherited forms are known, characterized by early (or juvenile) onset. For example, Best 
Vitelliform Macular Degeneration (BVMD) and Stargardt-like disease are both dominant 
inherited juvenile forms of macular degeneration (reviewed in Vasireddy et al., 2010; Xiao et 
al., 2010). These diseases are characterized by extensive accumulation of lipofuscin, yellow 
granules containing lipids, atrophy of the RPE and loss of the central vision, all clinical 
features shared by several forms of age-related macular degeneration. However, clinical 
profiles of inherited macular degeneration may vary among patients, indicating the 
intervention of other factors in modelling the disease. One of such factors could be oxidative 
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stress. Interestingly, susceptibility to the onset of macular degeneration is increased by 
oxidative damage that leads to cumulative mutations in mitochondrial DNA of retina cells 
(reviewed in Jarrett et al., 2010). 
3. Animal models for retinopathies 
Because animals develop retinal diseases with similar traits as in humans, they are 
commonly used to improve our understanding of the molecular pathogenesis of hereditary 
retinal degeneration. Animal models can also serve to screen compounds for therapeutic 
use. Different species such as mice, rats, dogs, cats and even pigs have contributed to the 
study of retinal degeneration (reviewed in Fletcher et al., 2011; Rivas and Vecino, 2009). 
Describing all these different models is beyond the aims of this review. Thus, in this section 
we will focus on some models mimicking retina degeneration, which greatly contributed to 
the elucidation of molecular pathways underlying the different retinopathies. 
3.1 Mouse models for retina degeneration 
Natural mutant mice or knock-out animals allowed to identify several important genetic 
factors involved in retina degeneration. Importantly, these genes share analogous mutations 
in human. In addition, the effects on retinal structure and function of gene mutations 
associated with retinal diseases can also be tested by means of transgenesis. In many cases 
the proteins encoded by these genetic factors were shown to be sensible targets for 
pharmacological treatments or gene therapy, giving important results in terms of clinical 
and medical investigation. Below, we will give a brief overview of the different mouse 
models used to mimic RP or AMD, describing the degenerative mechanisms they 
contributed to elucidate (see also Table 1). 
3.1.1 Mouse models for RP: Mutations in rhodopsin 
The rod visual pigment rhodopsin, a G-protein coupled receptor that initiates the visual 
transduction cascade, was the first protein found to be mutated in RP. Rhodopsin mutations 
are responsible for 30–40% of autosomal dominant forms of RP (reviewed in Fletcher et al., 
2011; Wang et al., 2005). One of the most common mutation in human rhodopsin is the 
substitution of proline for histidine in position 23 (P23H) (Dryja et al., 1990). Mice 
expressing such mutated rhodopsin develop significant photoreceptor degeneration, with a 
consequent decrease in visual function (Olsson et al., 1992). Importantly, photoreceptor 
degeneration was also observed in control transgenic mice overexpressing wild type 
rhodopsin. Together, these data suggested that the expression levels of either normal or 
aberrant rhodopsin may play a role in triggering cell death (Olsson et al., 1992). Based on 
cell culture and transgenic mice, it was shown that most rhodopsin mutants interfere with 
the folding, the stability and/or the transport to the membrane of rhodopsin protein 
(Kaushal et al., 1994; Roof et al., 1994; Wang et al., 2005). However, since different results are 
obtained in various animal models, the exact mechanisms underlying rhodopsin-dependant 
photoreceptor cell degeneration is still not well understood and remains controversial. 
Therefore, generating additional, more appropriate, animal models is still an issue. Along 
this line, a knock-in mice model expressing P23H rhodopsin was recently reported and 
highlighted defective glycosilation and rapid degradation of the mutant protein, in addition 
to disorganization of the rod outer segments, which may account for photoreceptor 
degeneration (Sakami et al., 2011). 
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3.1.2 Mouse models for RP: Mutations affecting phototransduction pathway 
Among the genes involved in phototransduction cascade, phosphodiesterase 6 (PDE6) genes 
are the most studied. Phosphodiesterase 6 is a hetero-tetrameric enzyme consisting of one α, 
one ß and two γ subunits, involved in cGMP (cyclic guanosine monophosphate) breakdown. 
Mutations in any of the three subunits give rise to recessive forms of RP. Most of the 
knowledge on the molecular mechanisms concerning this specific form of RP comes from 
studies on one mouse strain, known as Retinal degeneration 1 (rd1), where the PDE6B gene, 
encoding the ß subunit, is mutated. The corresponding mutation in humans accounts for 
about 5% of the recessive forms of RP (http://www.sph.uth.tmc.edu/retnet/). These 
animals are natural loss of function mutants closely mimicking the human disorder. In these 
mice, non-functional PDE6B protein leads to accumulation of high levels of cGMP in the 
rods (Paquet-Durand et al., 2009). Thus, the sustained levels of cations contribute to 
constantly depolarize rod photoreceptors, eventually causing these cells to die. More 
recently, it has been shown that cyclic nucleotide-gated ion channels (CNGs) play a pivotal 
role in the PDE6B-dependent cell death mechanism (Paquet-Durand et al., 2011). These 
channels allow the influx of Na+ and Ca2+ inside the cells in a cGMP-dependent manner, and 
increased levels of cGMP are correlated with excessive intracellular concentration of Ca2+ 
ions. Indeed, as a confirmation of these results, knock-out mice for Cngb1 gene (lacking rod 
CNGs) in a rd1 mutant background, show a substantial rescue of rod and cone cell-
morphology and function, compared to single rd1 mutants. These double mutant mice show 
also an increased rate of photoreceptor survival compared to the single mutant rd1 (Paquet-
Durand et al., 2011). Thus, the results reported here argue for a major role of CNGs and 
calcium in triggering rod degeneration. 
3.1.3 Mouse models for RP: Mutations affecting photoreceptor structural proteins 
Photoreceptor outer segments are continuously renewed to replace proteins and lipids that 
are damaged by light and highly oxidative environment. Maintenance of the integrity and 
renewal of the outer segment disk membranes is thus critical for correct photoreceptor 
function. Peripherin is an integral membrane protein that localizes to the rim of 
photoreceptor outer segments and was proposed to act as a structural element for the outer 
segment membranes (Connell and Molday, 1990; Molday et al., 1987). Mutations in 
Peripherin (PRPH) are a common cause for autosomal dominant RP, accounting for about 5% 
of the cases (reviewed in Boon et al., 2008). Retina degeneration slow (rds) mice are 
naturally occurring homozygous mutants, carrying a mutation in the Peripherin gene 
(Connell et al., 1991; Travis et al., 1989). These mice are characterized by photoreceptor 
degeneration and abnormal morphological features in the outer segment discs. Transgenic 
mice, carrying an aminoacid substitution (P216L) in the Peripherin protein were generated 
(Kedzierski et al., 1997). These mice exhibited photoreceptor loss proportional to the level of 
transgene expression. Importantly, photoreceptor outer segments displayed abnormal 
shortening and central lacunae, confirming the hypothesized role for Peripherin in the 
stabilization of outer segment architecture and thereby in the viability of photoreceptors. 
The underlying mechanisms remain however to be further explored for the future 
development of therapeutic strategies. 
3.1.4 Mouse models for RP: Mutations affecting ciliary proteins 
The photoreceptor connecting cilium, a structure that connects the inner (having the 
metabolic machinery) with the outer segment (containing phototransduction proteins), 
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mediates trafficking of factors involved in phototransduction. It is therefore not surprising 
that mutations in photoreceptor cilium proteins have been reported to cause RP, and in 
particular X-linked RP, which is the most severe form in terms of age onset and progression 
(reviewed in Hosch et al., 2011; Murga-Zamalloa et al., 2009). Mutations in retinitis 
pigmentosa GTPase regulator (RPGR) and retinitis pigmentosa GTPase regulator interacting 
protein (RPGRIP) genes account for about 70% of X-linked RP (Vervoort et al., 2000). RPGR 
protein localizes to the connecting cilium, and mice knock-out for this protein exhibit 
progressive photoreceptor degeneration. Notably, basal disc membranes were strongly 
disorganized in these mice, and opsin mislocalization or reduction was observed (Hong et 
al., 2000). Even though RPGR is a ciliary protein, the cilium structure seems to be well 
preserved in knock-out mice. This may indicate that RPGR regulates activities like protein 
transport along the cilium, more than its biogenesis/maintenance. Consistent with this, it 
was recently reported that RPGR interacts with RAB8A, which is a critical GTPase involved 
in photoreceptor protein trafficking, and that this interaction may account for photoreceptor 
degeneration in patients with RPGR mutations (Murga-Zamalloa et al., 2010). RPGRIP 
knock-out mice also show photoreceptor degeneration and outer segment discs appear 
oversized and disorganized (Zhao et al., 2003). Importantly, in these mice RPGR protein 
appears mislocalized, indicating that RPGRIP is involved in tethering RPGR to the 
connecting cilium. RP1 is another ciliary factor, a photoreceptor-specific microtubule-
associated protein, whose mutation gives rise to common forms of autosomal dominant RP 
(5-10% of the cases). Mice expressing C-terminal truncation of this protein (resembling 
human disease-associated mutations) were created (Liu et al., 2003). These mice developed 
significant photoreceptor degeneration. Analysis of the phenotype indicated that RP1 could 
play a fundamental role in the organization of the outer segment discs. Given the important 
phenotype heterogeneity observed in patients with cilium associated RP, it is critical to 
further characterize animal models carrying mutations in cilium proteins to better 
understand the pathogenesis of these RP diseases. 
3.1.5 Mouse models for age-related macular degeneration 
Due to its complex genetic components and to the role played by environmental factors, 
AMD is more difficult to be modelled in mice. Furthermore, mice do not possess a well-
defined macula, which is particularly affected in human AMD. Notwithstanding, it is 
possible to mimic some forms of AMD, as well as juvenile inherited forms of macular 
degeneration, using knock-out or transgenic mouse models (reviewed in Elizabeth Rakoczy 
et al., 2006; Fletcher et al., 2011). Stargardt’s disease is a juvenile inherited form of macular 
degeneration, where defects in lipid biosynthesis and transport occur (reviewed in Molday 
and Zhang, 2010). ABCR (a member of ABC transporter family) null mice are used to mimic 
recessive form of Stargardt’s disease while transgenic mice expressing the human mutant 
form of ELOVL4 (an enzyme that catalyzes the elongation of very long-chain fatty acids) 
mimic the autosomal dominant Stargardt-like disease (Karan et al., 2005; Weng et al., 1999). 
In both the mutant mice, accumulation of lipofuscin granules in RPE is observed and is 
correlated with photoreceptor loss. Indeed, lipofuscin accumulation is one of the hallmarks 
of several forms of macular degeneration. The studies of these mice allowed to hypothesize 
that accumulation of lipofuscin (and its main component, the fluorophore A2E) into RPE 
cells would result in toxicity and death of these cells, with deleterious secondary 
consequences on photoreceptors. 
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Knock-in mice expressing a mutated form (W93C) of Bestrophin anion channel revealed to 
be a good model of the inherited form of macular degeneration, BVMD (Best vitelliform 
macular dystrophy, Zhang et al., 2010). The aminoacid substitution present in this mutated 
protein exerts a dominant negative effect on the channel activity. Indeed, these mice 
developed several features typical of BVMD, like retinal detachment in central region of the 
eye, accumulation of debris like shed outer segment, lipofuscin and lipid droplets. 
Furthermore, calcium signalling was suppressed in the transgenic mice. Such findings 
suggest that calcium may play a pivotal role in the pathogenesis of BVMD. Furthermore, 
since BVMD is the second cause of juvenile inherited macular degeneration (following 
Stargardt’s disease), their use is thought to generate important data for therapeutical 
approaches. Other models, like mice lacking monocyte chemoattractant protein-1 (Ccl-2) or 
its cognate C-C chemokine receptor-2 (Ccr-2) also develop characteristic features of AMD, 
like drusen, lipofuscin accumulation and choroidal neo-vascularization (CNV), as well as 
photoreceptor degeneration (Ambati et al., 2003). Importantly, choroidal macrophage 
recruitment was impaired in Ccl-2-/- and Ccr-2-/-, leading to accumulation of complement 
C5a and IgG proteins. This accumulation, in turn, leads to overexpression of vascular 
endothelial growth factor (VEGF) by RPE, likely mediating the CNV phenotype. Other 
interesting factors have been shown to play a role in RPE degeneration and development of 
particular forms of AMD. Mice lacking functional Dicer1 in the RPE, for example, develop  
 
Mouse models for RP 
Affected proteins Affected genes Inheritance Phenotype 
Rod visual pigment Rhodopsin 
Autosomal 
dominant 
Defects in Rhodopsin sorting, glycosilation 
and/or folding, resulting in cell toxicity 
Phototransduction 
proteins 
PDE6B Recessive 
High cGMP and calcium levels, determining 
cell death 
Structural proteins PRPH 
Autosomal 
dominant 
Rod outer discs abnormalities, leading to 
photoreceptor death 
Ciliary proteins 
RPGR, RPGRIP     
RP1 
X-linked              
Autosomal 
dominant 
Defects in disc membrane organization and 
protein sorting/localization, leading to cell 
death 
 
Mouse models for AMD 
Disease category 
Affected 
genes 
Phenotype 
Juvenile inherited forms 
of macular degeneration 
ABCR, 
ELOVL4, 
Bestrophin 
Lipofuscin accumulation, resulting in RPE degeneration 
Dry AMD (geographic 
atrophy) 
Dicer1 
Accumulation of Alu RNAs, which results in RPE cell 
dismorphology and death 
AMD (general features) Ccl-2, Ccr-2   
Accumulation of drusen and lipofuscin, choroidal neo-
vascularization, leading to cell death 
Table 1. Main mouse models for RP or AMD, discussed in the present manuscript. 
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RPE dysmorphology similar to those observed in humans affected by geographic atrophy 
(or dry AMD) and RPE degeneration (Kaneko et al., 2011). Importantly, Dicer1 depletion in 
RPE results in increased levels of Alu RNAs, which are responsible for the cell death. Thus, 
a variety of different mechanisms appear to be involved in different steps, or forms, of 
AMD. 
3.1.6 Mouse models and therapies for retina degeneration  
The plethora of data obtained from the studies on mouse models has provided potential 
targets of pharmaceutical interest. Some Ca2+ channel blockers were found to efficiently 
protect photoreceptor of rd1 mice from degeneration. For example D-cis-diltiazem, a cGMP-
gated channel blocker used to treat cardiac disfunctions, was shown to slow down 
photoreceptor degeneration and to preserve visual function in rd1 mice (Frasson et al., 1999). 
More recently, similar observations were extended to other calcium channel blockers, able to 
preserve photoreceptor viability in mouse models for retinal degeneration (Takano et al., 
2004). These results confirm cGMP-gated channels as important pharmacological targets for 
treating some forms of RP, like PDE6B recessive RP. Other factors play an important role in 
preserving photoreceptor viability. For example, cytotoxicity in P23H mutant mice was 
exacerbated by lack of 11-cis-retinal chromophore, thus indicating an important role for this 
molecule in protecting from P23H-induced cell death(Sakami et al., 2011). Indeed, 
pharmacological replacement of 11-cis-retinal (as well as other retinoids) showed beneficial 
effects in the treatment of several forms of retina degeneration (Palczewski, 2010). Proteins 
may be also used to treat retina degeneration. It was shown that injection of rod-derived 
cone viability factor (RdCVF), a protein secreted by rod cells, is able to protect cone cells 
from death in rd1 mice (Leveillard et al., 2004). This observation is particularly important, 
since cones affection in late stages of RP is responsible for legal blindness. Thus, due to its 
ability to maintain cones viable and to preserve their function, future therapeutic strategies 
in humans should consider the possibility to deliver RdCVF protein in the patients’ retina, 
or to promote its expression from unaffected cells (Leveillard and Sahel, 2010). Besides 
RdCVF, systemic administration of Insulin in rd1 mice increased the rate of cone survival 
(Punzo et al., 2009). It is evident that different therapeutic strategies are becoming available 
to promote photoreceptor maintenance. 
However, drug or molecule treatment is not the only strategy that can be used for this aim. 
Gene therapy, for example, showed promising results in treating some forms of RP in 
mouse models. Indeed, adeno-associated virus serotype 5 (AAV5) has been recently used to 
deliver mouse rhodopsin in P23H transgenic mice (Mao et al., 2011). These mice (which 
mimic autosomal dominant RP) showed significant rescue of photoreceptor function 
(assessed by electroretinogram recording) as well as photoreceptor viability. Although it is 
still not known how wild type rhodopsin rescues the dominant effect of mutated rhodopsin, 
this result is encouraging in the view of gene therapy treatment of human RP. Several 
clinical trials have shown to be effective in improving visual function in patients affected by 
Leber’s congenital amaurosis (a recessive retinal degeneration) (Bainbridge et al., 2008; 
Simonelli et al., 2010). Thus, delivery of functional rhodopsin could represent a valid option 
for treating RP. However, since high rhodopsin levels can result in toxicity for rod cells, 
much work is still required to optimize these therapies in humans. Recently, adeno-
associated vectors were used to deliver human RPGRIP1 gene in mouse models of Leber’s 
congenital amaurosis (Pawlyk et al., 2010). Expression of RPGRIP1 was able to improve rod 
and cone survival in the retina of these mice. 
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Different approaches have been designed to treat also AMD. Importantly, many of these 
approaches have been designed to target wet (exudative) AMD (reviewed in Querques et 
al., 2011). As we have seen, one of the hallmarks of wet AMD is the process of 
neovascularization, which is correlated to severe visual loss. To this regard, several 
strategies aim to block the process of blood vessel formation, to minimize the effects of 
macular degeneration. Indeed, antibodies against the angiogenic factor VEGF, like 
Ranibizumab, have demonstrated successful in blocking VEGF-dependent angiogenesis in 
patients affected by AMD, improving their visual functions (for a review, see Lien and 
Lowman, 2008). Not all the antibodies against VEGF are able to efficiently penetrate the 
retina, and some of them show important side-effects. Thus, AAV-assisted gene therapy 
seems to be a valid alternative to this approach. In particular, AAV2-mediated intravitreal 
delivery of chimeric forms of VEGF receptor Flt-1 showed promising results in mouse 
models (Pechan et al., 2009). In these oxygen-induced retinopathy models, the AAV-
delivered chimeric proteins were able to inhibit efficiently angiogenesis, showing no 
detectable signs of toxicity. Thus, these results show promising candidate molecules for the 
treatment of human AMD by gene therapy. 
Despite the abundance of strategies to target wet AMD, no therapies are available for 
treating dry or atrophic AMD (Querques et al., 2011). However, a recent study shows a 
potential and important therapeutic target. As seen above, Alu RNAs were shown to induce 
cytotoxicity in murine RPE cells, which developed a degeneration phenotype similar to 
atrophic AMD (Kaneko et al., 2011). Notably, subretinal administration of antisense 
oligonucleotides, which targeted and reduced Alu RNAs, inhibited efficiently the 
degeneration phenotype in vivo (Kaneko et al., 2011). Thus, this study reveals a promising 
target for blocking RPE degeneration typical of AMD. Inherited forms of macular 
degeneration are also current targets of therapeutic treatment. For example, administration 
of vitamin A to murine models of Stargardt’s disease was shown to efficiently decrease the 
accumulation of lipofuscin, and to improve visual function (Ma et al., 2010). In a different 
approach, lentiviral-mediated delivery of human ABCA4 gene in Abca4-/- mice showed 
effective reduction in the accumulation of the lipofuscin pigment A2E (Kong et al., 2008). 
Thus, gene therapy could also be used to treat genetic forms of macular degeneration. 
3.2 Alternative models for retina degeneration 
Besides the mouse models reported above, other mammalian animal models are used to get 
insights into the pathogenesis of inherited retina degeneration, such as rat, dog or pig. 
However, because the development of the retina and its morphology are remarkably 
conserved in all vertebrates, non-mammalian species have also emerged during the last 
decade as alternative valuable models. In particular, zebrafish, which is well suited for 
large-scale genetic screens, revealed to be very informative in the elucidation of the 
processes underlying retina degeneration (reviewed in Bibliowicz et al., 2011; Brockerhoff 
and Fadool, 2011; Li et al., 2010). Its importance is strengthened by the fact that not all the 
murine models are suitable to mimic a particular pathological feature or for the 
development of pharmacological therapies. In zebrafish, a dozen different genetic lesions 
have been identified leading to photoreceptor cell death, belonging to different functional 
classes. For example, mutation in the gene encoding the cone specific phosphodiesterase c 6 
(pde6c) was shown to induce cone cell death, similarly to pde6b-induced rod cell death in 
mouse models (Stearns et al., 2007). Importantly, some rod cells also died in these mutant 
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fish, primarily in areas where rod density was low. This result suggests an important 
correlation between secondary cell death and cell density. Another recent study taking 
advantage of zebrafish as a model system provided novel insights into the pathogenic 
potential of disease-associated mutations in RPGR (Ghosh et al., 2010). 
The frog Xenopus laevis also recently revealed important in deciphering the mechanisms 
underlying photoreceptor degeneration (Tam and Moritz, 2006; Tam and Moritz, 2007; Tam 
and Moritz, 2009; Tam et al., 2006; Zhang et al., 2008). For example, transgenic frogs 
expressing different glycosylation-deficient forms of rhodopsin showed rod degeneration 
when rhodopsin glycosylation was inhibited in position N15 (Tam and Moritz, 2009). 
Strikingly, the photoreceptor degeneration was exacerbated when the frogs were exposed to 
light, while was attenuated in dark-reared animals. This result suggests that glycosylation is 
involved in rhodopsin stabilization, particularly after its activation by light. Studies on 
Xenopus also showed that the localization of rhodopsin is important for photoreceptor 
viability. In fact, in transgenic frogs expressing a rhodopsin bearing C-terminal truncation 
(Q350Ter), mutant rhodopsin (but not wild type endogenous rhodopsin) failed to correctly 
localize and induced a severe form of photoreceptor degeneration (Tam et al., 2006). 
Importantly, in this case degeneration occurred even in the dark, indicating that the toxic 
effects of mislocalized rhodopsin were independent from its activation. Additionally, since 
Xenopus retina contains numerous cone cells (differently from mice) this system would 
allow to examine more easily the secondary effects of rod death on cone viability. 
4. Studying retina regeneration in vivo 
The animal models described so far have greatly contributed to the understanding of 
mechanistic processes of retina degeneration. Furthermore, as we have seen, this knowledge 
has revealed instrumental in the excogitation of valid medical approaches. However, even 
though the available therapies lead to amelioration of the degeneration, these treatments 
cannot compensate for the cells that have been already lost, often limiting their efficacy to 
the early steps of the pathology. In order to compensate for this limitation, regenerative 
medicine aims at developing treatments that improve, or even induce, regeneration of lost 
cells, a process that involves formation of newly born cells, which then differentiate to 
replace dead cells. 
In order to identify mechanisms and molecules that mediate retina regeneration, it is 
opportune to work with suitable animal models. The mouse models reported in the last 
section are not appropriate for deep examination of regenerative processes. One reason is 
that higher vertebrates show little regenerative potential. Moreover, the transgenic, knock-
out or natural mutant models presented above do not offer the possibility to control 
experimentally the duration of degeneration. Such a requisite is essential to observe the 
mechanisms acting during regeneration: first, one would induce degeneration of a particular 
retinal cell type; then, by blocking the degenerative processes, it would be possible to allow 
the regeneration to occur. This system would offer the possibility to study genes and 
pathways regulating regeneration. 
Thus, the first problematic is the choice of the animal model. Amphibians such as frogs and 
salamanders, and fishes show a strong regenerative potential, maintained for a great part of 
their life. Importantly, it seems that part of the regenerative program active in lower 
vertebrates is still present in higher vertebrates like birds and mammalian, which  show a 
limited and short regenerative response upon injuries (reviewed in Karl and Reh, 2010). 
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Thus, the complete understanding of the regenerative program in fish and frogs would 
provide a basis in designing effective strategies able to stimulate or enhance this process in 
humans affected by degenerative retinopathies. 
The second problematic is how to induce and to reverse the process of retina degeneration. 
Several methods can be employed to this aim: for example, it is possible to induce the death 
of photoreceptor (both rods and cones) by exposing dark-adapted animals to strong white 
light (Reme et al., 1995; Vihtelic and Hyde, 2000), or by using laser to mediate cell ablation 
(Wu et al., 2001). Small molecules can also be used to destroy retina cell types: mature 
photoreceptors are particular sensitive to N-Methyl-N-nitrosourea (MNU) (Tsubura et al., 
2011), while exposure to high level of glutamate can induce death of retinal ganglion cells 
(RGCs), a finding that has been linked to several cases of glaucoma (Dreyer et al., 1996). 
Neurotoxins like ouabain can also be used to damage RGCs and cells of the inner nuclear 
layer (Fimbel et al., 2007; Sherpa et al., 2008). Logically, removing the drug or switching off 
the light source would block the degenerative event, allowing the system to recover and to 
regenerate. Finally, surgical methods can also be employed to remove small part of the 
retina, for example by cutting a portion of retina with a surgical blade or by pricking it with 
a needle (Cameron, 2000; Fausett and Goldman, 2006; Goldsmith and Harris, 2003; Vergara 
and Del Rio-Tsonis, 2009; Yoshii et al., 2007). 
Although these strategies do not resemble generally a particular pathway occurring during 
human retina degenerative diseases, they offer the important advantage of controlling the 
timing and duration of degenerative treatment. However, the systems here described 
present also a limitation: for example light can be used to kill only photoreceptors, while 
chemicals or physical damage may lack enough specificity, affecting more than a particular 
cell type. Thus, in the recent years more elegant and fine tuned systems have been 
developed, like transgenic animals expressing an inducible and reversible cytotoxic gene 
under control of a retina specific promoter. Below, we will give examples of transgenic 
animal models which are thought to bring great contribution to the study of regeneration.  
4.1 Transgenic models for regeneration studies 
Transgenic animals offer the unique possibility to selectively induce cell death (provided 
that a cell or tissue specific promoter is available) through the use of a cytotoxic gene whose 
activity is inducible and reversible. One powerful and elegant system to induce specific cell 
ablation in fish and frogs, in an inducible and reversible fashion, is the 
nitroreductase/metronidazole (NTR/mtz) system (Figure 1). Bacterial NTR is a flavoprotein 
enzyme able to reduce nitro group-containing substrates. When a non-toxic molecule like 
mtz (prodrug), is reduced by NTR, it is converted into a powerful DNA cross-linker agent 
leading to cell death by apoptotic mechanisms. Thus, mtz can be added into the water of 
animals expressing NTR under the regulation of a cell-specific promoter to induce cell death 
only in those cells expressing the enzyme. Cells not expressing NTR are not directly affected 
by the prodrug mtz, validating the high specificity of the system. Subsequently, mtz can be 
removed by washing the transgenic animals in mtz-free water, allowing the study of the 
cellular and molecular processes of regeneration (Curado et al., 2007; Curado et al., 2008; 
Davison et al., 2007; Pisharath, 2007; Pisharath et al., 2007).  
In the context of the retina, NTR/mtz system has been used to induce cell death successfully 
in different retina cells of zebrafish and Xenopus laevis, using enhancer traps or specific 
promoters (Choi et al., 2011; Montgomery et al., 2010; Zhao et al., 2009). In particular, 
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A: Schematic diagram representing a chimeric GFP-tagged NTR under the control of a specific 
promoter. This construct is used to create transgenic frogs. B: Ventral view of a stage 41 transgenic 
tadpole carrying a GFP-NTR transgene under the control of the rod specific Xop promoter. C: 
Magnification of the onset shown in B, showing GFP fluorescence in the eye. D-F: Transversal retinal 
section of such a transgenic tadpole, following anti-GFP (green, D) and anti-rhodopsin (red, E) 
immunostaining. The merge image (F) confirms the rod specificity of expression. G: magnification of 
the onset shown in F. l = lens; nr = neural retina. Scale bar in B=2 mm, scale bar in D=20 µm.  
Fig. 1. The NTR/mtz transgenic system in frogs.  
transgenic Xenopus frogs were obtained, expressing NTR under the control of rhodopsin 
promoter (Xop::NTR). This model is of particular importance, since it mimics human RP. 
Indeed, when tadpoles at stage 50 were exposed to mtz, their rods started to die soon after 
the treatment. Furthermore, when mtz treatment was prolonged, cone degeneration was 
also observed following rod cell death, a characteristic of RP (Choi et al., 2011). Importantly, 
upon mtz removal, newly born rods were observed in a time-range of thirty days, indicating 
successful regeneration of death cells. Regeneration studies were conducted also in zebrafish 
retina, where rod or bipolar cells were targeted for ablation. Again, treatment with mtz 
induced specific ablation of NTR-expressing cells, while removal of the prodrug allowed 
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regeneration of rods and bipolar interneurons in a short period (Montgomery et al., 2010; 
Zhao et al., 2009). Altogether, these data show that the NTR/mtz system is a powerful tool 
to induce cell-death in a specific and reversible fashion, which can be applied to animals 
with regenerative capacity to investigate the molecular pathways governing the 
phenomenon of regeneration. 
Other cytotoxic genes can also be used to achieve retinal cell death. For example, an 
inducible form of caspase-9 (iCasp9) was expressed in Xenopus rod photoreceptors by using 
rhodopsin promoter (Hamm et al., 2009). This inducible caspase is activated by the drug 
AP20187, added to the tadpoles’ medium, thus leading to death of rod cells. Similarly to 
mtz, AP20187 can be removed at any time, thus switching off the stimulus for rod death. 
These frogs developed abnormalities in the function of cone cells, assessed by 
electroretinogram. Importantly, cone functionality was restored 6 months after the 
treatment, confirming the reversibility of this model. However, differently from the 
Xop::NTR Xenopus model, no clear signs of cone apoptosis were observed, although the 
reasons of this difference are not known. In conclusion, different systems can be employed 
to induce death of specific cell types, enabling the study of their regeneration and the 
secondary consequences related to their death on neighbouring tissues. 
4.2 Sources of regeneration 
In order to understand the retina regenerative process, the first question to answer is which 
cells are able to set off the regeneration? Although mammals are devoid of a regenerative 
capacity, they possess cells with stemness features in the ciliary body, a structure derived 
from the optic cup, lying between the retina and the iris. Although these cells remain 
mitotically quiescent in vivo, they are able to clonally expand in vitro (Ahmad et al., 2000; 
Coles et al., 2004; Tropepe et al., 2000). Although the proliferative and differentiation 
potential of such ciliary body-derived cells towards the photoreceptor lineage is 
controversial (Cicero et al., 2009; reviewed in Locker et al., 2010), this raises the question 
whether and how it is possible to stimulate the proliferative and differentiation ability of 
these cells in vivo, to regenerate injured cells. Lower vertebrates on the other hand possess a 
region, adjacent to ciliary body, called ciliary marginal zone (CMZ), where active 
proliferating retinal stem and progenitor cells reside. These cells, capable of generating all 
types of retinal neuron and glial cells, contribute to the perpetually expanding retina of 
these animals, which grow throughout life (reviewed in Otteson and Hitchcock, 2003; Wetts 
and Fraser, 1988; Wetts et al., 1989). CMZ cells were shown to contribute to the replacement 
of retinal cells after injury (reviewed in Locker et al., 2009; Locker et al., 2010; Moshiri et al., 
2004). However, it seems that the origin of regenerating cells can be species-specific and 
changes according to the developmental stage.  
4.2.1 CMZ and RPE as a source of retina regeneration 
If retina is surgically removed in urodele amphibians, like salamanders, RPE cells respond 
to injury by re-entering the cell cycle. These cells undergo a process of transdifferentiation, 
loosing features of differentiated RPE like their pigmentation, and form a new (inner) layer 
which will give rise to a complete retina, with normal lamination and apparently functional 
(Araki, 2007). In the anuran amphibian Xenopus, both stem cells of the CMZ and cells 
constituting the RPE are able to regenerate the injured retina. The contribution of CMZ in 
Xenopus retina regeneration was already known since 1982 (Mitashov and Maliovanova, 
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1982). When neural retina was removed, partial regeneration of neural retina was observed 
by proliferating stem cells normally present in the CMZ. However, it was also shown that, 
upon surgical retinectomy, cells of RPE delaminated and migrate toward the retinal vascular 
membrane (RVM), forming a new layer (Yoshii et al., 2007). The cells of this layer 
transdifferentiate, as assessed by expression of neural retina markers. Importantly, the 
pigmented cells were intermingled with other cells deriving from the CMZ, which also 
contributed to the newly formed neural retina. This study suggested also a role for RVM in 
the process of regeneration, which could be fundamental. Although the molecular nature of 
RVM contribution in regeneration remains still elusive, it could act likely through the 
secretion of particular growth factors into extracellular matrix. Indeed a possible role for this 
tissue in retina regeneration was observed already in 1987 in a study on the amphibian Rana 
catesbienna, where close contact between RVM and delaminated RPE was observed (Reh and 
Nagy, 1987). Its importance is also underlined by the fact that, when absent, the neural 
retina is not able to regenerate. When neural retina was surgically removed, together with 
the RVM, no regeneration occurred in tadpoles, unless specific growth factors were added 
to the operated eyes (Vergara and Del Rio-Tsonis, 2009). Further work is required in order to 
fully elucidate the modalities through which RVM act during regeneration. It is important to 
note, at this point, that the mechanisms of regeneration observed in amphibians are also 
present in higher vertebrates such as chicken, although this potential is limited to a short 
temporal window. The hatched chicken retina indeed also possesses a CMZ, although with 
a more limited potential compared to that of fish and amphibians (Fischer and Reh, 2000). 
Thus, both RPE and stem cells residing in the ciliary body/CMZ are able to contribute to 
retinal regeneration, until approximately embryonic day 4.5 (E4.5) (reviewed in Spence et 
al., 2007b). 
4.2.2 Müller glia as a source of retina regeneration 
RPE and CMZ are not the only origin of regeneration. Müller glia were also shown to 
display neurogenic capacity and to contribute to the regenerative process following retinal 
injury in diverse vertebrate retinas (Bernardos et al., 2007; Das et al., 2006; Fausett and 
Goldman, 2006; Fischer and Reh, 2001; Fischer and Reh, 2003; Monnin et al., 2007; Yurco and 
Cameron, 2005). For instance, upon photoreceptor cell death in transgenic zebrafish 
expressing NTR in rod cells, Müller cells were observed to re-enter the cell cycle. This 
yielded clusters of neural progenitor cells, which later on differentiated in rod cells 
(Montgomery et al., 2010). It is important to note, however, that Müller glia was mobilized 
only when the damage to rod cells was extensive: when mosaic transgenic lines, expressing 
NTR only in a small subset of rods, were treated with mtz to induce cell death, only 
specialized Müller glia-derived progenitors committed to rod lineage (known as rod 
precursor cells) were activated for regeneration. This result demonstrates that factors, like 
the extent of damage, can influence the source of regeneration. The role of Müller glia in 
regeneration has been observed in other studies. Upon light damage in zebrafish, Müller 
glia cells re-enter the cell cycle and de-differentiate, as judged by the loss of specific 
differentiation markers such as GFAP (glial fibrillary acidic protein) and Glutamine 
Synthetase. Successively, these cells start to express neural marker such as Pax6, and form 
neurogenic clusters that migrate toward the outer nuclear layer, where photoreceptors 
reside (Thummel et al., 2008a). In particular, ability of glial cells to re-enter the cell cycle is 
fundamental for the regeneration. Indeed, inhibition of Müller glia division, by knock-down 
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of PCNA (proliferating cell nuclear antigen), inhibited proliferation and expression of neural 
markers such as Pax6 (Thummel et al., 2008b). This resulted in failure to regenerate 
photoreceptors in zebrafish light-damaged retinas confirming that Müller glia, upon 
proliferation, can serve as a major source of retinal regeneration. Importantly, lineage 
tracing experiments indicate that Müller glia can regenerate all retinal cell types, 
demonstrating the high plasticity of these cells (Ramachandran et al., 2010b). However, the 
neurogenic potential of activated Müller glia seems to be limited, as particular mature 
retinal cell types are rarely or never regenerated following injury (Fischer and Reh, 2001; 
Ooto et al., 2004). Nonetheless, this can be experimentally overcome by treatment with 
specific soluble factors (Ooto et al., 2004; Osakada et al., 2007) raising the possibility that 
Müller glia could be stimulated to produce specific retinal cell types, provided exogenous 
supply of endogenously limiting factors. 
What initiates the regenerative response of Müller glia? This question remains still largely 
unanswered, however a fascinating hypothesis points to its role in phagocytosis of dead 
photoreceptors. Interestingly, it was observed that Müller cells were able to engulf apoptotic 
bodies derived from light-damaged photoreceptors. Upon phagocytosis of dead cells, it was 
reported that Müller glia started to proliferate, as assessed by PCNA immunolabelling, and 
successively regenerated dead cells (Bailey et al., 2010). On the other hand, when 
phagocytosis was blocked by means of inhibitors, the process of regeneration failed to occur. 
In mammalian retina, Müller glia can be activated in response to injury, becoming 
hypertrophic. However, very few cells enter the cell cycle (Bringmann et al., 2009). Thus, 
understanding the signals that activate these cells toward a regeneration program is a 
necessary step to successfully induce retinal regeneration in mammals. 
4.3 Candidate genes and signaling pathways involved in regeneration 
In the previous section, we have discussed about the sources of regeneration in lower 
vertebrates, identifying the RPE, the CMZ and the Müller glia as the main generator of 
regeneration. What are the molecular signals that activate these cells in response to retina 
injury? To date, a network of different genes and signaling has been shown to act during 
regeneration. An important goal of regenerative medicine is to characterize the network in 
fine details, so that this knowledge can be used to promote retinal regeneration in patients 
affected by retinopathies. 
4.3.1 Transcription factors promoting regeneration 
Several transcription factors involved in early retinogenesis were shown to be essential for 
regeneration to occur. It has been recently reported in Xenopus tadpoles that the 
transcription factor Rx1, a paired like homeobox gene fundamental for early eye field 
specification, plays a central role in retinal regeneration (Martinez-De Luna et al., 2011). 
When retina was physically damaged, retinal progenitor cells were found to migrate near 
the site of wound and to initiate regeneration of the entire damaged retina. However, when 
Rx1 was knocked-down by means of small hairpin RNA (shRNA), defects in morphology of 
progenitor cells were observed, together with a reduced expression of progenitor markers. 
Examples of transcription factors acting during Müller glia-dependant regeneration come 
from studies in zebrafish. Indeed, the proneural transcription factor Ascl1 is essential for the 
regeneration process in the fish (Ramachandran et al., 2010a). Ascl1 mRNA is rapidly 
induced in dedifferentiating Müller glia, and it is necessary for the transcription of the 
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pluripotency RNA binding protein Lin-28. Lin-28, on its turn, inhibits the biogenesis of Let-7, 
a miRNA associated with the repression of regeneration-associated genes including Ascl1 
itself, hspd1 and Pax6b. Thus, while normally Let-7 is implicated in maintaining the 
differentiation status of Müller glia, its Ascl1/Lin28-mediated downregulation in response to 
injury is a pre-requisite for the re-entry in the cell cycle and dedifferentiation of the glial 
cells. The activity of Pax6a and Pax6b transcription factors is also essential for the division of 
the glia-derived neuronal progenitors. Both genes are expressed in Müller glia soon after the 
retinal damage (Raymond et al., 2006). Their knockdown in zebrafish reduced the number of 
inner nuclear layer proliferating neuronal progenitors, resulting in a corresponding loss of 
regenerated photoreceptors (Thummel et al., 2010). Pax6 was also shown to be sufficient, 
upon ectopic expression, to promote transdifferentiation of the RPE in the chick retina both 
during development (Azuma et al., 2005) and during the regenerative process (Spence et al., 
2007c). Due to their involvement in early retinal development, where such transcription 
factors regulate proliferation and specification of early retinal progenitors, it is plausible that 
they play an analogous role on the regenerating cells during the process of regeneration. 
However, such hypothesis remains to be tested and the details by which these factors act 
remain to be identified.  
4.3.2 Signaling molecules involved in regeneration 
To discover novel factors involved in retina regeneration, transcriptional profiles of injury-
activated Müller glial cells were generated from adult zebrafish, at the early stages of 
photoreceptor regeneration (Qin et al., 2009). The chaperone hspd1 and the mitotic 
checkpoint kinase mps1 were shown to be up-regulated in these cells. Subsequent functional 
analyses indicated that both factors are required for cone regeneration, at different steps of 
the process (Qin et al., 2009). Although the mutation in these genes was shown to inhibit 
neurogenic cluster formation and neuronal progenitor proliferation, the exact mechanisms 
underlying their activities remain unknown. Such genes, activated during regeneration play 
an obvious important role, yet they represent a downstream response to the initial event 
that damages the retina. This implies that there must be one or more signals that initiate the 
regeneration process. So far, several signaling molecules have been identified, which might 
play such a role. It is long known that the FGF (fibroblast growth factor) pathway is a critical 
inductive cue for retinal regeneration. Basic FGF-2 was indeed shown to induce RPE 
transdifferentiation in chick (Park and Hollenberg, 1989; Park and Hollenberg, 1991) and 
Xenopus (Sakaguchi et al., 1997). The importance of FGF-2 in Xenopus regeneration was 
confirmed also recently. Indeed, administration of FGF-2 was able to stimulate regeneration 
of a new entire retina in Xenopus tadpoles, where complete neural retina (and vascular 
membrane) was surgically removed (Vergara and Del Rio-Tsonis, 2009). Inhibition of the 
MAPK pathway reduced significantly the regeneration, highlighting its importance in retina 
regeneration. MAPK may regulate retina regeneration also in birds. For instance, over-
expression of a constitutively active form of MAPK (Mek-1) in the chick embryonic retina 
induced RPE transdifferentiation into neural retina, an event correlated with down-
regulation of the RPE-specific marker Mitf, and overexpression of Pax6 (Galy et al., 2002; 
Spence et al., 2007c). Among other critical factors, CNTF (ciliary neurotrophic tactor) was 
observed to stimulate Müller glia proliferation in zebrafish (Kassen et al., 2009) and BMP 
signaling was shown to regulate regeneration from the ciliary margin in chick, through 
Smad activation and upregulation of FGF/MAPK pathway (Haynes et al., 2007). Besides, 
Sonic hedgehog (Shh) also plays a key role in chick retina regeneration. In particular, 
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exogenous activation of Shh in cooperation with FGF activation induces regeneration from 
the ciliary body, by stimulating the proliferation of the cells residing in this region (Spence 
et al., 2007a; Spence et al., 2004). More importantly, it was observed that activation of 
analogous pathways were able to initiate retina regeneration even in mammals. The 
mammalian optic nerve does not regenerate when injured. However, significant 
regeneration can be achieved through exogenous administration of various growth factors. 
For example, intravitreous injections of CTNF strongly induced optic nerve regeneration in 
rats where the optic nerve was cut (axotomy). This effect was shown to strongly rely on 
MAPK activity, since inhibition of MAPK compromised the effects of CNTF on neurite 
outgrowth (Muller et al., 2009). Similarly, simultaneous administration of CNTF and 
inhibition of Rho kinase (Rock) promoted retinal ganglion cell survival and regeneration 
upon axotomy (Lingor et al., 2008). Hedgehog signaling could also represent a potential 
candidate pathway to stimulate mouse retina regeneration. Activation of Shh pathway in 
patched+/- (ptc+/-) mice results in persistent proliferating progenitors at the ciliary margin, 
resembling the CMZ of lower vertebrates. Importantly, such patched mutation in P23H mice 
was able to promote a partial rescue of the retina degeneration (Moshiri et al., 2004). 
The factors shown here are only some of the many known to be involved or stimulate retina 
regeneration. Although the list of these factors is in continuous expansion, our knowledge 
about their in vivo function modalities is still modest. The most important point emerging 
from the present data is that the mechanisms regulating regeneration seem to be conserved 
among vertebrates. In particular, there are some evidences that factors normally regulating 
regeneration in lower vertebrates can be successfully used to improve regeneration in higher 
vertebrates like birds and mammals. Thus, an interesting scenario emerges from these 
results: once a particular factor is identified to have a role during retina regeneration in 
animals showing regeneration, then it is important to test whether this factor is conserved in 
mammals and whether it has any ability to stimulate retina regeneration.  
5. Conclusion 
The promise of regenerative medicine is to induce regeneration of damaged tissues or entire 
complex structures in situ. Although mammalian possess a natural regenerative capacity, 
this is very limited and restricted to a few tissues, such as the liver and the skin. On the 
other hand, amphibians and fishes have extensive regenerative capacity. Concerning the 
retina, they are able to regenerate all the neurons and the glia of this fundamental tissue. 
Understanding precisely all the molecules and genes involved in this process, as well as the 
network of interactions that these form in vivo will be fundamental for a rationale screening 
of pharmacological drugs, able to trigger the precise regenerative process. Furthermore, the 
lower vertebrates adopt mechanisms, such as transdifferentiation and dedifferentiation, 
which mammalian does not seem to possess. In the next future, it will be important to 
determine exactly how Müller glia or RPE exploit these processes to regenerate damaged 
tissues, so that we could use them to initiate regeneration directly in vivo, in patients affected 
by degenerative retinopathies. 
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